Pharma companies that shift their attention to what providers, payers, and patients are asking for will profit from the growing worldwide market on preventative care.
This Continuing Education activity is supported by educational grants from AstraZeneca LP and Boehringer Ingelheim Pharmaceuticals, Inc.
When making coverage decisions in oncology, payers find difficulties in translating evidence on treatment effect heterogeneity into coverage policies.
Four major trends will dominate the health information technology landscape during the coming year.
Integrating specialty pharmacy staff into oncology, neurology, rheumatology, and other specialty clinics within their health systems is a growing trend with a range of beneficial outcomes.
Pharmacy team members can provide educational resources, strategies to kids to promote safety.
Pharmacist-administered vaccination services were found to be more efficient, productive, and cost-effective than primary care visits or mass vaccination clinics.
Dose optimization strategies offer a potentially valid, clinically based intervention in which payers can realize a direct drug cost savings, and indirect medical cost avoidance.
These 8 apps, offered by organizations such as the pediatric infectious diseases society and the CDC, feature vaccine schedules, risks, and more.
The Phaseal closed-system transfer device can extend the beyond-use date of pharmaceuticals, thereby reducing waste.
At the American College of Cardiology Scientific Session, a study of prescriptions for PCSK9 inhibitors confirms what doctors say about trying to get their patients access to the cholesterol drug.
Biosimilars are a potential solution to the ever-growing problem of high specialty drug costs.
A revealing GPhA research report on brand name and generic prescription drug sales demonstrates how much generic medicines have saved consumers, as well as state and federal governments, over the past decade.
Evidence suggests that they are not actively using their prescriptive authority, but a new study aims to identify factors affecting their related behaviors.
Although the use of preexposure prophylaxis against HIV has increased across the United States in recent years, the rise in costs across the health care system has yet to be fully catalogued.
In a review of publicly reported diabetes quality measures for Medicaid fee-for-service, overall reporting was low and reports of outcomes measures were rarely available.
Improvements in pruritus were achieved earlier with crisaborole for eczema.
This study characterizes the role of specialty drug utilization in aggregate private sector healthcare spending in the United States from 2000 to 2009.
Clinical trial results show that several new combination therapies offer great promise for the treatment of challenging neuroendocrine tumors in the gastrointestinal area.
Nonadherence is linked to poor health outcomes, including a decreased quality-of-life, disease progression, and increased hospitalizations.
For transplant patients, the difference between a successful and an unsuccessful outcome can be made by medication adherence.
This prospective randomized study suggests that ezetimibe 2.5 mg, delivered as an ezetimibe/simvastatin tablet split into 4 parts, is clinically equivalent to a 10-mg dose.
Whether its robots, microbots, smartphones, or 3-dimensional printing, the potential for technology to impact health care and pharmacy excites and motivates Dan Benamoz, RPh, founder and chief executive officer, Pharmacy Development Services.
According to the 2014 National Pharmacist Workforce Study, approximately 18.7% of women and 16.4% of men actively engaged as pharmacists reported working part-time.